Physician profile
Todd W Gensler
NPI 1922070309
$21,371.02
in general payments reported to CMS, 2019-2025
31 companies · $7,112 in 2025
The $7,112 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,720 · 2020: $327 · 2021: $466 · 2022: $2,724 · 2023: $2,857 · 2024: $5,166 · 2025: $7,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $3,775 · Travel and Lodging: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,478.03 |
| Consulting Fee | $3,775.00 |
| Travel and Lodging | $881.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,637.96 | 2021-2025 | Endurant Iis, Hawkone |
| Imperative Care, INC | $4,256.40 | 2024-2025 | Zoom 88-T Large Distal Platform, Symphony Catheter |
| W. L. Gore & Associates, INC. | $1,918.70 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Dryseal Flex Introducer Sheath |
| Bard Peripheral Vascular, INC. | $1,804.52 | 2019-2025 | Venovo, True Flow, Crosser Iq |
| Philips North America LLC | $1,322.55 | 2021-2025 | Igt Devices Undivided, (Bs1) Peripheral Vascular Undivided, (Br5) Peripheral Ivus |
| Penumbra, INC. | $861.55 | 2022-2025 | Indigo System, Penumbra System |
| Endologix LLC | $843.49 | 2021-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Silk Road Medical, INC. | $732.85 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $700.36 | 2019-2025 | Cook, Zilver Vena, Zenith Spiral-Z |
| Medtronic Vascular, INC. | $611.81 | 2019-2020 | |
| Boston Scientific Corporation | $525.58 | 2020-2025 | General - Vascular Intervention |
| Bolton Medical INC | $492.98 | 2020-2025 | Treo Abdominal Stent-Graft System, Gelweave |
| Abbott Laboratories | $397.03 | 2024-2025 | Esprit, Perclose Proglide |
| Shockwave Medical, INC | $382.24 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $356.38 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $305.20 | 2024-2025 | Spy-Phi System, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Smith+Nephew, INC. | $170.86 | 2020-2023 | Pico, Renasys Touch, Renasys Go V2 Home |
| Baxter Healthcare | $166.18 | 2023 | Preveleak |
| Ge Healthcare | $159.67 | 2023 | |
| Shape Memory Medical INC. | $148.71 | 2025 | Impede Embolization Plug |
| Cardiovascular Systems INC. | $147.40 | 2022 | |
| Surmodics, INC. | $119.21 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Kci USA, INC. | $100.00 | 2023 | V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
| Janssen Pharmaceuticals, INC | $97.31 | 2023 | Xarelto |
| Getinge USA Sales, LLC | $23.15 | 2019-2020 | |
| Becton, Dickinson and Company | $22.16 | 2024 | Covera |
| Cordis US Corp. | $18.70 | 2025 | Exoseal |
| Convatec INC. | $17.50 | 2020 | |
| Tactile Systems Technology INC | $16.45 | 2020 | |
| Lemaitre Vascular, INC. | $14.12 | 2023 | Hydro Lemaitre Valvulotome |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Gensler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.